Consolidated cash flow statements
(unaudited)
|
Three months ended 31 March |
|
---|---|---|
(thousands of €) |
2022 |
2021 |
Net profit/loss (-) of the period |
(13,310) |
9,361 |
|
|
|
Adjustment for non-cash transactions |
9,652 |
(7,980) |
Adjustment for items to disclose separately under operating cash flow |
3,125 |
792 |
Adjustment for items to disclose under investing and financing cash flows |
- |
(28,842) |
Change in working capital other than deferred income |
40,111 |
19,673 |
Decrease in deferred income |
(97,418) |
(113,164) |
|
|
|
Cash used in operations |
(57,840) |
(120,161) |
|
|
|
Interest paid |
(3,964) |
(1,482) |
Interest received |
633 |
648 |
Corporate taxes paid |
(799) |
(214) |
|
|
|
Net cash flows used in operating activities |
(61,969) |
(121,209) |
|
|
|
Purchase of property, plant and equipment |
(9,178) |
(8,488) |
Purchase of and expenditure in intangible fixed assets |
(487) |
(243) |
Purchase of current financial investments |
(1,422,417) |
(201,188) |
Interest received related to current financial investments |
- |
6 |
Sale of current financial investments |
502,193 |
677,032 |
Cash in from disposals of subsidiaries, net of cash disposed of |
- |
28,696 |
Acquisition of financial assets |
(3,564) |
- |
Proceeds from sale of financial assets held at fair value through profit or loss |
- |
4,045 |
|
|
|
Net cash flows generated from/used in (-) investing activities |
(933,453) |
499,859 |
Payment of lease liabilities |
(2,184) |
(1,780) |
Proceeds from capital and share premium increases from exercise of subscription rights |
2,160 |
2,258 |
|
|
|
Net cash flows generated from/used in (-) financing activities |
(25) |
478 |
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(995,446) |
379,129 |
|
|
|
Cash and cash equivalents at beginning of year |
2,233,368 |
2,143,071 |
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(995,446) |
379,129 |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
16,358 |
31,750 |
|
|
|
Cash and cash equivalents at end of the period |
1,254,279 |
2,553,950 |
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
31 March |
|
---|---|---|
(thousands of €) |
2022 |
2021 |
Current financial investments |
3,389,098 |
2,560,743 |
Cash and cash equivalents |
1,254,279 |
2,553,950 |
Current financial investments and cash and cash equivalents |
4,643,377 |
5,114,693 |
The accompanying notes form an integral part of these condensed consolidated financial statements.